2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Remimazolam: new trials by email Literature Review of Remimazolam trials Research Report on Remimazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty Remimazolam 20 MG Injection [Byfavo], NaCl 0.9% - Remimazolam, Emergence Delirium | Phase 2 | Unknown | University Hospital of Split | 80 | 2024-03-06 | 2024-05-03 |
| Trial Evaluating the Efficacy of Remimazolam in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Byfavo, Midazolam - Midazolam, Remimazolam | Phase 2 | Unknown | Yeungnam University Hospital | 330 | 2024-03-01 | 2024-02-23 |
Confusion (1) · Delirium (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Signs and Symptoms (1)
remimazolam (2) · Injections (1) · Midazolam (1) · Sodium Chloride (1)
University Hospital of Split (1) · Yeungnam University Hospital (1)
Croatia (1) · South Korea (1)